Guidelines for clinical trials of new therapeutic agents in multiple sclerosis: Reporting extended results from phase III clinical trials

✍ Scribed by D. E. Goodkin; S. Reingold; W. Sibley; J. Wolinsky; H. McFarland; D. Cookfair; F. Lublin

• Publisher: John Wiley and Sons
• Year: 1999
• Tongue: English
• Weight: 88 KB
• Volume: 46
• Category: Article
• ISSN: 0364-5134
• DOI: 10.1002/1531-8249(199907)46:1<132::aid-ana22>3.0.co;2-z